erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via inhibiting cystine transportation in gastric cancer (IGCC 2025) - May 17, 2025 - Abstract #P498; Pres time: May 8, 2025; "In models, SLC7A9 suppression or inhibition with erastin showed therapeutic potential... SLC7A9 expression was up-regulated in gastric cancer tumor tissues and negatively correlated with overall survival. SLC7A9 conferred resistance to ferroptosis in gastric cancer cells. P53 acted as a repressive transcription factor regulating SLC7A9 expression in gastric cancer." 
Gastric Cancer • Oncology • Solid Tumor • GPX4
https://www.igcc2025.org/resources/uploads/sites/164/2025/05/Abstarct-book-IGCC-.pdf
 
Li J1; Feng H1; Zhu Z1; Liu B1
 
May 17, 2025
 
Prev Next